These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12708738)

  • 21. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S; Reddy R
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract]   [Full Text] [Related]  

  • 22. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
    Manickam P; Nagaraju B; Selvaraj V; Balasubramanyam S; Mahalingam VN; Mehendale SM; Pannikar VK; Gupte MD;
    Indian J Lepr; 2012; 84(3):195-207. PubMed ID: 23484334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy.
    Gupte MD
    Lepr Rev; 2000 Dec; 71 Suppl():S77-80. PubMed ID: 11201893
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
    Lockwood DN
    Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
    [No Abstract]   [Full Text] [Related]  

  • 27. Population screening and mass chemoprophylaxis in Kiribati.
    Daulako EC
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S23-5. PubMed ID: 10700933
    [No Abstract]   [Full Text] [Related]  

  • 28. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986
    [No Abstract]   [Full Text] [Related]  

  • 29. Population screening and chemoprophylaxis for household contacts of leprosy patients in the Republic of the Marshall Islands.
    Tin K
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S26-9. PubMed ID: 10700934
    [No Abstract]   [Full Text] [Related]  

  • 30. Newer drugs in leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H
    Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL; Stefani MM; Pereira GA; Costa MB; Rebello PF; Gomes MK; Narahashi K; Gillis TP; Krahenbuhl JL; Martelli CM
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
    Singh HB; Katoch K; Natrajan M; Sharma RK; Gupta UD; Sharma VD; Singh D; Chauhan DS; Srivastava K; Katoch VM
    Acta Leprol; 1999; 11(4):179-82. PubMed ID: 10987049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM; Ibanez MA
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
    Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of leprosy in the federated states of micronesia by intensive case finding, treatment with WHO/MDT and administration of chemoprophylaxis.
    Diletto C
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S10-3. PubMed ID: 10700929
    [No Abstract]   [Full Text] [Related]  

  • 37. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
    Ji B; Sow S; Perani E; Lienhardt C; Diderot V; Grosset J
    Antimicrob Agents Chemother; 1998 May; 42(5):1115-20. PubMed ID: 9593137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leprosy situation in endemic states of India and prospects of elimination of the disease.
    Subramanian M; Showkath Ali MK; Thorat DM; Muthukumar M; Sathiskumar E; Ramadoss C; Ali Khan M
    Indian J Lepr; 2003; 75(4):335-45. PubMed ID: 15242272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M; Gupte MD
    Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of rifampin in infections of normal mice with Mycobacterium leprae.
    Grosset JH; Guelpa-Lauras CC
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):847-51. PubMed ID: 3437168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.